Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The functional impact of SLC6 transporter genetic variation.

Annual review of pharmacology and toxicology - 1 Jan 2007

Hahn Maureen K, Blakely Randy D

Abstract excerpt

Solute carrier 6 (SLC6) is a gene family of ion-coupled plasma membrane cotransporters, including transporters of neurotransmitters, amino acids, and osmolytes that mediate the movement of their substrates into cells to facilitate or regulate synaptic transmission, neurotransmitter recycling, met...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attention Deficit Disorder with Hyperactivity
Share to Biological Transport
Share to Bipolar Disorder and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depression

Share to Multigene Family

Share to Mutation

Share to Neurotransmitter Receptor Influence on Behavior

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 17067279
DOI: 10.1146/annurev.pharmtox.47.120505.105242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17067279-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The functional impact of SLC6 transporter genetic variation.PMID 17067279Read ↗

Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and diseaseSemantic proximity Read ↗

SLC6A4 polymorphism, population genetics, and psychiatric traitsSemantic proximity Read ↗

Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy.Semantic proximity Read ↗

Pathogenic mechanisms underlying SLC6A1 variant-mediated neurodevelopmental disorders.Semantic proximity Read ↗

PharmGKB submission update: VI. PMT submissions of genetic variations in neurotransmitter transporters (SLC6, SLC17, and SLC18) to the PharmGKB network.Semantic proximity Read ↗

Population genetic variation of SLC6A4 gene, associated with neurophysiological development.Semantic proximity Read ↗

Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531Semantic proximity Read ↗

Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.Semantic proximity Read ↗

Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing.Semantic proximity Read ↗

5HTTLPR: White Knight or Dark Blight?Semantic proximity Read ↗

Worldwide population variation and haplotype analysis at the serotonin transporter gene SLC6A4 and implications for association studies.Semantic proximity Read ↗

Sequences and polymorphisms of the canine monoamine transporter genes SLC6A2, SLC6A3, and SLC6A4 among five dog breeds.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.